EVIS X1

Discussion in 'Olympus Endoscopy' started by anonymous, Apr 24, 2020 at 1:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What's the word, gang!?! Is this new tank a step up - or to be tossed out? Inquiring minds want to know!
     

  2. anonymous

    anonymous Guest

    Saw a glimpse of this on my way out. It has meaningful new technology, and will open a door to further technology that will disrupt healthcare. Competitors are always playing catch up, this will be no different.
    Fuji is still cheaply made and trying to copy the last cycle of technology. It is as if they photocopied the brochure of the 190 series (8 years old) with their latest platform. They will continue to be the "rebound" brand that doesn't last - and nibble around the edges of the market for those who put price ahead of quality and technology. Fuji is a threat in some locations due to price but their quality will always be their downfall. Cheap price, cheap quality, cheap sales team.

    Pentax is under funded and poorly supported, largely an after thought across most of the country. Ambu and Boston trying to enter the scope market will chip away at certain segments but are not functional enough to disrupt, yet.
    Anyone with the market share Olympus has, struggles to keep it and that will continue to be the case for the market leader, but it is the leader for a reason.

    Still, happy to be out of the industry and no longer playing these games! Cheers, friends - good luck with the launch.